MedTrace Logo

Immune Response of Patients With Chronic, Staphylococcus Aureus-infected Wounds

NCT01551667 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 69

Last updated 2016-04-06

No results posted yet for this study

Summary

The primary objective of this study is to detect differences in anti-S. aureus antibody assays (IgM, IgA, IgG and its subclasses) between (1) a group of patients with bacteremia due to a chronic wound (cases) and (2) a group of patients with localized chronic wound infections (control).

Conditions

  • Diabetic Foot
  • Foot Ulcer
  • Leg Ulcer
  • Bacteremia
  • Infection

Interventions

BIOLOGICAL

Antibody assays for S. aureus

Antibody assays for S. aureus at Day 0, Day 2, Day 4, Day 7, Day 30 and Month 6.

BIOLOGICAL

Basic blood work

Hemogramme + CRP on Days 0, 2, 4 and 7

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Principal Investigators

  • Jean-Philippe Lavigne, MD PhD · Centre Hospitalier Universitaire de Nîmes

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01551667 on ClinicalTrials.gov